|
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Relationship between neurokinin 2 receptor gene polymorphisms and serum vascular endothelial growth factor levels in patients with toluene diisocyanate-induced asthma.
|
16961715 |
2006 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
The levels of HIF-1α and VEGF increased in lung tissue and bronchial fluid of patients with asthma and in the nasal fluid of patients with rhinitis after challenge.
|
21517900 |
2011 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
It has been shown that treatment of asthma patients decreases VEGF levels, and inhibition of VEGF diminishes asthma symptoms in mice.
|
22519966 |
2012 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In addition, there were no correlations between VEGF levels and asthma control test scores.
|
26996348 |
2017 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
EBT is increasing in severe asthma and is significantly modulated by VEGF levels.
|
29176061 |
2018 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Allergen treatment and lung-specific vascular endothelial growth factor (VEGF) expression induced asthma-like pathologies in the murine lungs.
|
21595947 |
2011 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
VEGF levels were measured in respiratory secretions from patients with asthma, before and during rhinovirus-induced exacerbations.
|
16461129 |
2006 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Vascular endothelial growth factor overexpression in induced sputum of children with bronchial asthma.
|
18298425 |
2009 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Administration of VEGF receptor inhibitors reduced the pathophysiologic signs of asthma and decreased the increased expression of MMP-9 after ovalbumin inhalation.
|
16645174 |
2006 |
|
Asthma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
PDGFBB and VEGF levels were significantly associated with asthma.
|
31586492 |
2019 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Vascular endothelial growth factor (VEGF) has been implicated in inflammatory and airway blood vessel remodeling in asthmatics.
|
31831011 |
2019 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
C. pneumoniae infection of BECs may play a role in the pathogenesis of asthma through the enhanced production of CCL20 and VEGF.
|
19479364 |
2009 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Acute and chronic changes of vascular endothelial growth factor (VEGF) in induced sputum of toluene diisocyanate (TDI)-induced asthma patients.
|
15201500 |
2004 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
CTD_human |
Manganese (II) induces chemical hypoxia by inhibiting HIF-prolyl hydroxylase: implication in manganese-induced pulmonary inflammation.
|
19263519 |
2009 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
LHGDN |
The aim of this study was to compare vascular endothelial growth factor (VEGF) and its receptor foetal liver kinase (Flk)-1 expression between seasonal AR patients with or without asthma and non-allergic controls as well as that between AR patients with and without asthma.
|
17651148 |
2007 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Immunomodulatory role of vascular endothelial growth factor and angiopoietin-1 in airway remodeling.
|
17168735 |
2006 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma.
|
23391391 |
2013 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
LHGDN |
Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses.
|
16461129 |
2006 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
The cytokine and potent angiogenic factor vascular endothelial growth factor (VEGF) plays an important role in airway remodelling in various airway diseases such as idiopathic pulmonary fibrosis, pulmonary hypertension, lung cancer, asthma and chronic obstructive pulmonary disease (COPD).
|
17906365 |
2007 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Role of licochalcone A in VEGF-induced proliferation of human airway smooth muscle cells: implications for asthma.
|
28635361 |
2017 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Experimental models and expression studies suggest that anti-vascular endothelial growth factor (VEGF) receptor strategies may be of use in patients with emphysema, whereas anti-HER1-directed strategies may be more useful in patients with pulmonary mucus hypersecretion, as seen in chronic bronchitis and asthma.
|
17406066 |
2007 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Vascular endothelial growth factor (VEGF) has been implicated in inflammatory and airway blood vessel remodeling in asthma.
|
28056993 |
2017 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
VEGFA was a hub protein in both the PPI networks of DEGs in notSA vs. NC and SA vs. NC.
|
27842724 |
2017 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Nasal VEGF was also measured in a cohort of asthmatics with verified rhinovirus and respiratory syncytial virus (RSV) infection.
|
16555282 |
2006 |
|
Asthma
|
0.400 |
Biomarker
|
disease |
BEFREE |
We conclude that ASM-derived VEGF, through modulation of the extracellular matrix, may play an important role in airway remodeling seen in asthma.
|
14633511 |
2004 |